Literature DB >> 32857613

The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma.

Salvatore Grisanti1, Deborah Cosentini1, Marta Laganà1, Alberto Dalla Volta1, Carlotta Palumbo2, Guido Alberto Massimo Tiberio3, Sandra Sigala4, Alfredo Berruti1.   

Abstract

Entities:  

Keywords:  Adrenocortical carcinoma; PD-L1; hypercortisolism; immune checkpoints inhibitors; immunogenicity; immunotherapy; progression-free survival; tumor infiltrating lymphocytes

Year:  2020        PMID： 32857613     DOI： 10.2217/fon-2020-0686

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  5 in total

1.  Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer.

Authors:  Elisa Rossini; Mariangela Tamburello; Andrea Abate; Silvia Beretta; Martina Fragni; Manuela Cominelli; Deborah Cosentini; Constanze Hantel; Federica Bono; Salvatore Grisanti; Pietro Luigi Poliani; Guido A M Tiberio; Maurizio Memo; Sandra Sigala; Alfredo Berruti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

2.  Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma.

Authors:  Deborah Cosentini; Antonella Turla; Ornella Carminati; Salvatore Grisanti; Vittorio Domenico Ferrari; Marta Laganà; Giovanni Rosti; Sandra Sigala; Alfredo Berruti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-22       Impact factor: 5.555

3.  Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic Review.

Authors:  Fausto Petrelli; Francesca Consoli; Antonio Ghidini; Gianluca Perego; Andrea Luciani; Paola Mercurio; Alfredo Berruti; Salvatore Grisanti
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

Review 4.  Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen.

Authors:  Antonella Turla; Marta Laganà; Salvatore Grisanti; Andrea Abate; Vittorio Domenico Ferrari; Valentina Cremaschi; Sandra Sigala; Francesca Consoli; Deborah Cosentini; Alfredo Berruti
Journal:  Endocrine       Date:  2022-05-14       Impact factor: 3.925

5.  Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma.

Authors:  M Laganà; S Grisanti; R Ambrosini; D Cosentini; A Abate; M Zamparini; V D Ferrari; A Gianoncelli; A Turla; L Canu; M Terzolo; G A M Tiberio; S Sigala; A Berruti
Journal:  ESMO Open       Date:  2022-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.